Overview
Dr. Lynce received her medical degree from the Universidade Nova de Lisboa, Portugal in 2004. She completed her residency in Internal Medicine and fellowship in Hematology and Medical Oncology at MedStar Washington Hospital Center/MedStar Georgetown University Hospital in Washington, DC. She was faculty at MedStar Georgetown University Hospital from 2015 to 2020 where she served as the institutional PI for Alliance and the co-PI for the National Capital Area (NCA) Minority/Underserved NCORP. In 2020, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Her research focuses on inflammatory breast cancer, triple-negative breast cancer, BRCA-associated breast cancers and novel therapies in the treatment of breast cancer.
Dr. Lynce is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, Angiosarcoma, and Salpingo-Oophorectomy.
Her clinical research consists of co-authoring 98 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles and participated in 3 clinical trials in the study of Triple-Negative Breast Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
450 Brookline Avenue, Susan F. Smith Center For Women's Cancers, Boston, MA 02115
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
11 Clinical Trials
Dana-Farber Cancer Institute, Inc.
Sara Tolaney is a Hematologist Oncology specialist and an Oncologist in Boston, Massachusetts. Dr. Tolaney is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and Inflammatory Breast Cancer. Dr. Tolaney is currently accepting new patients.
Affinity Physicians Llc.
William Sikov is a Hematologist Oncology specialist and a Hematologist in Warwick, Rhode Island. Dr. Sikov has been practicing medicine for over 44 years and is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, HER-2 Positive Breast Cancer, and Paget Disease of the Breast.
The General Hospital Corporation
Leif Ellisen is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Ellisen is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. His top areas of expertise are Breast Cancer, BRCA Positive Breast Cancer, HER2 Negative Breast Cancer, and Triple-Negative Breast Cancer. Dr. Ellisen is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Lynce isElite. Learn about Breast Cancer.
- Inflammatory Breast Cancer
- Triple-Negative Breast Cancer
- Advanced
- AgranulocytosisDr. Lynce isAdvanced. Learn about Agranulocytosis.
- AngiosarcomaDr. Lynce isAdvanced. Learn about Angiosarcoma.
- Febrile NeutropeniaDr. Lynce isAdvanced. Learn about Febrile Neutropenia.
- Paget Disease of the BreastDr. Lynce isAdvanced. Learn about Paget Disease of the Breast.
- Experienced
- Brain TumorDr. Lynce isExperienced. Learn about Brain Tumor.
- Endometrial CancerDr. Lynce isExperienced. Learn about Endometrial Cancer.
- HER-2 Positive Breast CancerDr. Lynce isExperienced. Learn about HER-2 Positive Breast Cancer.
- HER2 Negative Breast CancerDr. Lynce isExperienced. Learn about HER2 Negative Breast Cancer.
- Metastatic Brain TumorDr. Lynce isExperienced. Learn about Metastatic Brain Tumor.
- Ovarian CancerDr. Lynce isExperienced. Learn about Ovarian Cancer.